Optimizing transfusion management of multiple myeloma patients receiving daratumumab‐based regimens
Sign Up to like & getrecommendations! Published in 2021 at "Transfusion"
DOI: 10.1111/trf.16425
Abstract: Daratumumab, a human anti‐CD38 monoclonal antibody used to treat multiple myeloma, interferes with pretransfusion testing and can mask alloantibodies. Incidence of alloimmunization in patients on daratumumab has not been well characterized, and optimal transfusion guidelines… read more here.
Keywords: daratumumab; multiple myeloma; transfusion; transfusion management ... See more keywords